Search for: "In re Biogen Inc. Securities Litigation"
Results 1 - 11
of 11
Sorted by Relevance
|
Sort by Date
17 Mar 2022, 2:32 pm
The litigators should just thank the Fed Cir. for their part in ensuring their job security. [read post]
23 Jun 2010, 8:00 am
Biogen IDEC Inc., 537 F.3d 35, 48 (1st Cir. 2008). [read post]
14 Feb 2018, 2:57 pm
In re Lehman Brothers Securities & ERISA Litigation, 655 F. [read post]
16 Mar 2020, 1:54 pm
An early example of Lorenzo having an impact (albeit short-lived) in private litigation is In re Longfin Corp Sec. [read post]
17 May 2021, 1:03 pm
Paul is a partner in the securities litigation group at the Seyfarth Shaw law firm and Greg is co-head of the securities litigation group at Seyfarth Shaw. [read post]
5 Sep 2015, 11:58 am
A different three-judge panel on Sept. 1 said information of a clinical trial wasn’t evidence that could be used to challenge Biogen Inc. [read post]
25 Jun 2015, 5:00 am
Biogen Idec, Inc., 28 F. [read post]
1 Feb 2008, 12:00 am
: (IPBiz),State of the Union address 28 Jan 2008: statement regarding patenting human life: (IPBiz), (Patently-O),Alnylam Pharmaceuticals secures UK patent covering molecules that affect RNA interference: (SmartBrief),Doha style compulsory licences for exports: The politics…: (Spicy IP),Pushing to compulsory licensing: Pharma companies heading closer to Doha: (Spicy IP),Financial Express on the battle between big pharma companies and the… [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution –… [read post]
18 Apr 2008, 2:00 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Ranbaxy and AstraZeneca reach agreement in Esomeprazole patent litigation: (SmartBrief), (IPBiz), (Spicy IP), (Profitability through Simplicity), (IP Law360), (Philip Brooks), (GenericsWeb), Cadbury loses Australian battle over exclusive use of colour purple for chocolate wrapping in its case against Darrell Lea: (Australian Trade Marks… [read post]
29 Sep 2010, 12:49 pm
Signature Financial Group, Inc. [read post]
